Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection - Wikidata - awgldk - TriplyDB

Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection

Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection

http://www.wikidata.org/entity/Q35065094

about

Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management Update on surgical treatment of pancreatic neuroendocrine neoplasms Recent developments in imaging of pancreatic neuroendocrine tumors Therapy for metastatic pancreatic neuroendocrine tumors.Pancreatectomy with vein reconstruction: technique matters.Lymph nodes and survival in pancreatic neuroendocrine tumors.Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness.Pancreatic surgery with vascular reconstruction in patients with locally advanced pancreatic neuroendocrine tumors.Zollinger-Ellison syndrome: recent advances and controversies.Safety and outcome of combined liver and pancreatic resections.Imaging features of glucagonoma syndrome: A case report and review of the literature.Beyond the whipple operation: radical resections for cancers of the head of the pancreas.Pathology and Surgical Treatment of High-Grade Pancreatic Neuroendocrine Carcinoma: an Evolving Landscape.Glucagonoma syndrome: a review and update on treatment.Segmental portal/superior mesenteric vein resection and reconstruction with the iliac vein after pancreatoduodenectomy.Pancreatic neuroendocrine tumor with splenic vein tumor thrombus: A case report.Is superior mesenteric artery reimplantation during surgery for pancreaticoduodenal tumors an underutilized procedure?Resection strategies for neuroendocrine pancreatic neoplasms.Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI.Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract.Successful case of pancreaticoduodenectomy with resection of the hepatic arteries preserving a single aberrant hepatic artery for a pancreatic neuroendocrine tumor: report of a case.Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors.Abdominal mass, anemia, diabetes mellitus, and necrolytic migratory erythema.Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour.Surgical treatment of sporadic pancreatic neuroendocrine tumors: a state of the art review.Pancreatic neuroendocrine tumors Percutaneous Transhepatic Approach for Recanalization of Superior Mesenteric and Portal Vein in a Patient With Pancreatic Neuroendocrine Tumor Presenting With Bleeding Duodenal Varices: A Brief Case Report

P2860

Q26752757-F1FE79E5-3D96-4819-8050-2B2F1E4A78C4 Q26795597-8BCB4256-CB56-4BF6-B277-5FE85D66BF8D Q26864361-430E6CE8-824E-4142-8A45-459B44872E93 Q27005697-D98F9379-F60D-4C2B-96C3-42950E6AE14B Q34357869-795D3188-76BE-4EDA-A1B9-EA04516C3D14 Q36019703-10DBDA16-3702-45A6-BE9B-874759A0445F Q36250472-DA052570-53CB-4A4B-86C6-2C75E6AC1270 Q36311742-00AFE9C1-AD75-4489-AD65-F4A8CD38D581 Q36336998-88A8362B-D20D-43C8-953A-8C3ABBA83A25 Q36849357-7500A213-0D72-492D-9091-C074092B39AA Q37125550-FA22F2E2-4444-4B13-9CA5-B90630FA2932 Q37669053-1530A7DC-581B-4DA0-86A9-79757F42ADE2 Q38106646-55DA3E09-5916-4C38-9EAA-544888F723CD Q38150165-A2C91367-61DF-47C9-9F07-C64318DA5E96 Q38199388-A666E0ED-459D-4918-A829-434D7C90FA02 Q38383660-472F2238-E82E-4FBD-93ED-E7452FAFEB39 Q38456830-EE84521A-D4B1-43F5-A403-375129292CE6 Q38777613-0D525E05-4377-4FF0-BA80-2CF0BB4BFCAA Q38898616-8F6629F5-4ADB-46D3-894E-CE2D8D9C18D9 Q41010579-0F9D95F7-4D6D-42F7-AD90-0D3CD6979243 Q41763795-52D0CEB5-24A7-46C9-9E62-11CFA6BE3507 Q44123768-57AFD39A-9926-429B-9B52-F0F391823A1B Q44416053-FB86D314-4971-4BE8-8333-68382EC2E6CE Q44742028-FF88E567-DA91-45E8-9DD4-D267884A6FCD Q49820370-5E366510-6CE1-4089-9B4A-D78D3D8D4692 Q51755966-356EA3B7-068A-4A67-BF65-C625D9F56D62 Q53027231-2D86DD1A-4832-4AD0-8CDB-C424259E9E04 Q53191107-DAC057CB-83DD-438B-9837-82BF8CB9F7A4 Q55116336-B34BAF2B-33A6-4FDF-9738-38605698F8D1 Q55192213-3B6BA864-10DE-49A0-BD89-FABC6A8301CE Q56917284-D84916B5-34CC-41C9-8B9A-D6CC19F1DEA5 Q57300669-A20DA102-9848-4BCB-A85F-51DE730AA306

P2860

Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection

http://www.wikidata.org/entity/Q35065094

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Pancreatic endocrine tumors wi ...... t and indication for resection

@ast

Pancreatic endocrine tumors wi ...... t and indication for resection

@en

type

label

Pancreatic endocrine tumors wi ...... t and indication for resection

@ast

Pancreatic endocrine tumors wi ...... t and indication for resection

@en

prefLabel

Pancreatic endocrine tumors wi ...... t and indication for resection

@ast

Pancreatic endocrine tumors wi ...... t and indication for resection

@en

P1433

Q35065094-788F502B-886F-4A45-8A7C-E8F19C61F925

P1476

Q35065094-B9E5AB56-45D4-40F0-A563-495F82C73E00

P2093

Q35065094-02C2EE36-1F8F-4DC5-AA12-276A1387322B

Q35065094-04236360-F38E-4FFB-8622-D2CA54627443

Q35065094-0C69DA00-83FA-43B0-902D-EFAA80E6CB69

Q35065094-180F1E9E-749F-408D-928A-E4B60DEC86F0

Q35065094-96727FC3-7D81-4690-BF68-C60500A4BE8A

Q35065094-B99E0D2D-0CC4-4250-9B7E-5097662FB560

Q35065094-C220677E-FD01-428D-B86F-35C7CACE91C1

Q35065094-CAA3E4BA-F22B-4B19-99FE-B0387D3F9133

P2860

Q35065094-00ACA660-2B58-41A9-BEBE-4839B1B4C766

Q35065094-09FEDE39-1AA4-46C9-B37E-1FBCF269DCD6

Q35065094-0E700EC2-3E71-4C35-8CAC-510ED74D4DEE

Q35065094-0ED992CD-F701-43A2-ACE0-A9FA7800702D

Q35065094-134447BC-8B89-4980-95C5-A05A40A8C989

Q35065094-13E15FB6-3037-4E79-85AC-95B56D27501E

Q35065094-147E508E-BF0A-4600-8FA1-808E713DF7D0

Q35065094-1688F427-63BE-457A-B7C0-EAD4B5523DA4

Q35065094-16DCA9C2-275A-479B-AC0C-66926EDFADE2

Q35065094-17852398-1938-4B54-AABF-7D86C5A2592A

P304

Q35065094-96318BDC-EB23-4715-BD15-6250A5575E84

P31

Q35065094-47658532-6E90-460A-96D5-97DBC16AEB79

P356

Q35065094-CCD35D57-A59E-456C-9A5B-B8085293A0A8

P433

Q35065094-FB966991-4886-4021-980F-EFD9C05F0F59

P478

Q35065094-2ABF91E4-26A9-44F7-A0EE-6349B22C3758

P577

Q35065094-6248E578-AB66-4FAE-9A0C-0A949A6C0761

P5875

Q35065094-CBDFEED0-D758-4D7C-A79A-F7810E4F31E3

P698

Q35065094-F6667A2F-AEB8-4584-ADE9-DA49677E52F8

P932

Q35065094-40602A50-223F-4415-844C-1BA09494BA28

P356

ARCHSURG.2011.129

P1433

Archives of Surgery

P1476

Pancreatic endocrine tumors wi ...... t and indication for resection

@en

P2093

Brendan C Visser

http://www.w3.org/2001/XMLSchema#string

Edmund J Harris

http://www.w3.org/2001/XMLSchema#string

George A Fisher

http://www.w3.org/2001/XMLSchema#string

George A Poultsides

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Norton

http://www.w3.org/2001/XMLSchema#string

Pamela C Kunz

http://www.w3.org/2001/XMLSchema#string

Robert T Jensen

http://www.w3.org/2001/XMLSchema#string

Yijun Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases

Gastroenteropancreatic neuroendocrine tumours

Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors

Intraoperative methods to stage and localize pancreatic and duodenal tumors.

Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary.

Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups.

Gastric secretion in Zollinger-Ellison syndrome. Correlation with clinical expression, tumor extent and role in diagnosis--a prospective NIH study of 235 patients and a review of 984 cases in the literature.

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.

Hepatic surgery for metastases from neuroendocrine tumors.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

P304

724-732

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHSURG.2011.129

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

146

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51235787

http://www.w3.org/2001/XMLSchema#string

P698

21690450

http://www.w3.org/2001/XMLSchema#string

P932

3122162

http://www.w3.org/2001/XMLSchema#string